FlexMers BV is rated 3 out of 5 in the category biotechnology. Read and write reviews about FlexMers BV. FlexMers BV commercializes synthetic antibodies that are superior to natural antibodies with regard to affinity and selectivity. FlexMers has developed unique synthetic antibodies that allow for optimizing the distance between the two binding domains whereas natural antibodies have fixed and short distance between binding sites.
Company size
11-50 employees